Biogen Announces FDA Approves High Dose Regimen of SPINRAZA To Treat Spinal Muscular Atrophy

Benzinga Newsdesk www.benzinga.com Positive 90.0%

Neg 0% Neu 0% Pos 90%

Comments

No comments yet. Be the first!